**Core Concept:** The question is about active drug metabolites and their clinical usage in treating angina. Active drug metabolites are chemical compounds formed from the parent drug through the actions of cytochrome P450 enzymes in the liver, and may have different pharmacokinetic and pharmacodynamic properties compared to the parent drug. Angina is a clinical condition characterized by chest pain due to reduced blood flow to the heart muscles, often caused by coronary artery disease.

**Why the Correct Answer is Right:**

Correct Answer: C. Nitroglycerin

Nitroglycerin (glyceryl trinitrate, GTN) is an active nitric oxide (NO) donor, which acts as a vasodilator, reducing the workload of the heart. It relaxes the smooth muscle of blood vessels and coronary arteries, leading to increased blood flow and decreased angina symptoms.

**Why Each Wrong Option is Incorrect:**

A. Isosorbide Mononitrate (IMN) is another NO donor drug, similar to Nitroglycerin. However, it has a slower onset of action and longer duration of action compared to Nitroglycerin. Therefore, it is not the correct answer.

B. Verapamil is a calcium channel blocker. While it is also used for angina management, it is a different drug category compared to Nitroglycerin and does not act as an active nitric oxide donor.

D. Nicorandil is a potassium channel opener, which also belongs to a different class of angina medications (H2-blockers) than Nitroglycerin (NO donors). Nicorandil is a potassium channel opener, while Nitroglycerin is an active nitric oxide donor.

**Clinical Pearl:**

In clinical practice, understanding the pharmacology of active drug derivatives is crucial for proper drug selection and management of cardiovascular conditions like angina. Active nitric oxide donors like Nitroglycerin, Isosorbide Mononitrate, Verapamil, and Nicorandil are all used to manage angina, but their mechanisms of action differ significantly. This knowledge is essential for proper drug selection, dosage, and monitoring in clinical scenarios.